Tissue Regenix Group PLC (GB:TRX)
LSE:TRX
Holding GB:TRX?
Track your performance easily

Tissue Regenix (TRX) Financial Statements

10 Followers

Tissue Regenix Financial Overview

Tissue Regenix's market cap is currently ―. The company's EPS TTM is p-0.012; its P/E ratio is -49.29; Tissue Regenix is scheduled to report earnings on June 5, 2025, and the estimated EPS forecast is p0.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.95M$ 6.17M$ 7.71M$ 6.56M$ 12.97M
Total Assets$ 46.04M$ 44.49M$ 46.22M$ 34.31M$ 50.33M
Total Debt$ 9.61M$ 8.56M$ 7.95M$ 5.37M$ 7.22M
Net Debt$ 3.66M$ 2.39M$ 238.00K$ -1.19M$ -5.75M
Total Liabilities$ 15.64M$ 13.46M$ 12.83M$ 8.22M$ 12.06M
Stockholders Equity$ 31.25M$ 31.96M$ 34.34M$ 26.77M$ 39.03M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Tissue Regenix Earnings and Revenue History

Tissue Regenix Debt to Assets

Tissue Regenix Cash Flow

Tissue Regenix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis